TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
Yi Zhang(Zhengzhou University), Yiwei Chu(Fudan University), Luman Wang(Fudan University), Damo Xu(Wellcome Centre for Molecular Parasitology), Nan Liu(Shanghai Medical College of Fudan University), Yuchan Cai(Shanghai Medical College of Fudan University), Feifei Luo(Jiangxi University of Traditional Chinese Medicine)
Cited by 132
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k
Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
|Archives of General Psychiatry|2010|402